摘要
目的 研究艾迪注射液缓解癌痛及提高晚期癌症患者生存质量的作用。方法 晚期癌症患者 6 6例 ,其中伴有癌症疼痛患者 5 7例 ,占 86 .36 %。给予艾迪注射液 5 0～ 10 0ml静脉注射 1次 /d ,共用 30天 ,观察患者治疗前后疼痛缓解程度、生活质量改善情况、免疫功能变化及不良反应。结果 癌症疼痛控制总有效率达 75 .4 4 % (部分缓解 5 4 .37% ,完全缓解 2 1.0 5 % ) ,用药结束后疼痛缓解仍可维持 1～ 7天以上 ,且无成瘾性。 6 0例晚期患者生存质量有所提高。艾迪注射液对心、肝、肾功能无明显损害 ,4例患者伴有轻度静脉炎。结论 艾迪注射液在提高晚期癌症患者生活质量及控制癌痛中疗效满意 ,且安全可行。
Objective To evaluate the clinical effects of cancer pain control and life quality improvement in treating advanced cancers using Aidi injection. Methods 66 patients were treated by Aidi injection. among which 57 cases(86.36%) were with cancer pain,given Aidi injection 50～100ml,iv 1 time/d,for 30 days.The degree of pain relief , improvement of QOL and changes of immunological function were observed before and after treatment .Results The total cancer pain relief rate was 75.44%. (partial relief 54.37%,complete relief 21.05%) after the medicine the pain relief can last for 1～7 danys,No psychological dependence was noted , 60% patients had their QOL improved .Conclusion Aidi injection in the treatment of advanced cancer achieved a satisfied result and it is tolerable safely .
出处
《医药论坛杂志》
2004年第19期17-18,22,共3页
Journal of Medical Forum
